Company Press Releases

SJ Strategic Investments, LLC, Gracetree Investments, LLC, Gregory Asset Partners, LLC and the Gregory Irrevocable Equalizing Trust, acting jointly Files Early Warning Report

2017-09-01 / @newswire

VANCOUVER, British Columbia, Sept. 1, 2017 /PRNewswire/ -- SJ Strategic Investments, LLC, Gracetree Investments, LLC, Gregory Asset Partners, LLC and the Gregory Irrevocable Equalizing Trust, acting jointly (collectively the "Syndicate"), announced that they have filed an early warning report in...Read More

SJ Strategic Investments, LLC, Gracetree Investments, LLC, Gregory Asset Partners, LLC and the Gregory Irrevocable Equalizing Trust, acting jointly Files Early Warning Report

2017-09-01 / @newswire

VANCOUVER, Sept. 1, 2017 /CNW/ - SJ Strategic Investments, LLC, Gracetree Investments, LLC, Gregory Asset Partners, LLC and the Gregory Irrevocable Equalizing Trust, acting jointly (collectively the "Syndicate"), announced that they have filed an early warning report in respect of an offer (the "...Read More

Castle Silver Resources Updates Shareholders on Progress at Castle Silver-Cobalt Project in Ontario - Video Available on Investmentpitch.com

2017-09-01 / @newsfile

Vancouver, British Columbia--(Newsfile Corp. - September 1, 2017) -Castle Silver Resources (TSXV: CSR) (OTC: TAKRF) (FSE: 4T9B), continues to advance its Castle Silver-cobalt Project. The former silver and cobalt producing Castle Silver Mine Property, near Gowganda, Ontario, is located 85 kilometres...Read More

Calamos Closed-End Funds (NASDAQ: CHI, CHY, CSQ, CGO, CHW and CCD) Announce Monthly Distributions for September 2017

2017-09-01 / @newswire

NAPERVILLE, Ill., Sept. 1, 2017 /PRNewswire/ -- Calamos Investments (R)* announced today the declaration of monthly distributions on each common share of its six closed-end funds. Fund Distribution(Level Rate) Payabledate Recorddate Ex-dividenddate CHI (inception 06/26/2002)Calamos...Read More

CSR Advances Castle Silver-Cobalt Project

2017-08-31 / @newswire

COQUITLAM, BC, Aug. 31, 2017 /CNW/ - Castle Silver Resources Inc. (TSX.V: CSR, OTC: TAKRF, FRANKFURT: 4T9B) (the "Company" or "CSR") is pleased to provide the following update regarding its 100%-owned Castle mine, a prolific past silver producer with polymetallic potential near Gowganda, Ontario,...Read More

CSL Behring to Acquire Biotech Company Calimmune and its Proprietary Stem Cell Gene Therapy Platform

2017-08-28 / @newswire

KING OF PRUSSIA, Pa., Aug. 28, 2017 /PRNewswire/ -- Global biotherapeutics leader CSL Behring announced today that it has agreed to acquire Calimmune, Inc., a biotechnology company focused on the development of ex vivo hematopoietic stem cell (HSC) gene therapy with R&D facilities in Pasadena, Ca...Read More

Comstock Completes Summer Drilling Program at Preview SW Gold Project, Saskatchewan

2017-08-24 / @marketwired

VANCOUVER, BC--(Marketwired - August 24, 2017) - Comstock Metals Ltd. (TSX VENTURE: CSL) ("Comstock" or the "Company") is pleased to announce that it has completed the previously announced summer exploration program at its 100% owned Preview SW gold project, located 40 km northeast of La Ronge,...Read More

CobalTech and First Cobalt Sign Definitive Agreement

2017-08-21 / @marketwired

TORONTO, ONTARIO--(Marketwired - Aug. 21, 2017) - First Cobalt Corp. (TSX VENTURE:FCC)(OTCQB:FTSSF) ("First Cobalt") and CobalTech Mining Inc. ("CobalTech") (TSX VENTURE:CSK) are pleased to announce that, following the signing of a binding letter of intent June 23, 2017, they ha...Read More

Corsa Coal Announces Financial Results for Second Quarter 2017 and Results of Annual and Special Meeting

2017-08-16 / @newswire

CANONSBURG, PA, Aug. 16, 2017 /CNW/ - Corsa Coal Corp. (TSXV: CSO) ("Corsa"), a premium quality metallurgical, thermal and industrial coal producer, today reported financial results for the three and six months ended June 30, 2017 and announced the results of its annual and special meeting of sh...Read More

Berinert (R) Approved by Health Canada for the Treatment of Hereditary Angioedema (HAE) in Pediatric Patients

2017-08-09 / @newswire

OTTAWA, Canada, Aug. 9, 2017 /CNW/ -- CSL Behring is pleased to announce that on March 31st, 2017 Berinert (C1 Esterase Inhibitor, Human) was approved by Heath Canada for Pediatric Hereditary Angioedema (HAE). "HAE is an unpredictable and life threatening disease with few treatment options appr...Read More

eCobalt Provides Feasibility Study Update and Commences Pre-Construction Activities on the Idaho Cobalt Project

2017-08-09 / @newswire

VANCOUVER, Aug. 9, 2017 /CNW/ - eCobalt Solutions Inc. (TSX: ECS; OTCQB: ECSIF) (the "Company" or "eCobalt") is providing an update on its Feasibility Study ("FS") and recently initiated pre-construction activities on its 100% owned Idaho Cobalt Project ("ICP") in anticipation of final FS receipt...Read More

eCobalt Provides Feasibility Study Update and Commences Pre-Construction Activities on the Idaho Cobalt Project

2017-08-09 / @newswire

VANCOUVER, Aug. 9, 2017 /PRNewswire/ - eCobalt Solutions Inc. (TSX: ECS; OTCQB: ECSIF) (the "Company" or "eCobalt") is providing an update on its Feasibility Study ("FS") and recently initiated pre-construction activities on its 100% owned Idaho Cobalt Project ("ICP") in anticipation of final FS r...Read More

Calamos Closed-End Funds (NASDAQ: CHI, CHY, CSQ, CGO, CHW and CCD) Announce Monthly Distributions for August 2017

2017-07-31 / @newswire

NAPERVILLE, Ill., July 31, 2017 /PRNewswire/ -- Calamos Investments (R)* announced today the declaration of monthly distributions on each common share of its six closed-end funds. Fund Distribution(Level Rate) Payabledate Recorddate Ex-dividenddate CHI (inception 06/26/2002)Calamo...Read More

Capstone Mining Second Quarter 2017 Financial Results

2017-07-31 / @newswire

(All amounts in US$ unless otherwise specified) VANCOUVER, July 31, 2017 /CNW/ - Capstone Mining Corp. ("Capstone" or the "Company") (TSX: CS) today announced its financial results for the three and six months ended June 30, 2017. Cash flow from operating activities for the quarter was $4.1 mil...Read More

HAEGARDA (R) (C1 Esterase Inhibitor Subcutaneous [Human]) Now Available in the United States for Patients with Hereditary Angioedema

2017-07-25 / @newswire

KING OF PRUSSIA, Pa., July 25, 2017 /PRNewswire/ -- Global biotherapeutics leader CSL Behring announced today that HAEGARDA (R) (C1 Esterase Inhibitor Subcutaneous [Human]) is now available in the United States. The U.S. Food and Drug Administration (FDA) approved HAEGARDA on June 22, 2017...Read More

CSR Targets Asian Market for Cobalt

2017-07-25 / @newswire

COQUITLAM, BC, July 25, 2017 /CNW/ - Castle Silver Resources Inc. (TSX.V: CSR, OTC: TAKRF, FRANKFURT: 4T9B) (the "Company" or "CSR"), is pleased to provide a corporate update as the company advances its battery sector strategy through its proprietary Re-2OX process after recent meetings in Asia....Read More

CobalTech Clarifies Technical Disclosure

2017-07-24 / @marketwired

TORONTO, ON--(Marketwired - July 24, 2017) - COBALTECH MINING INC. (TSX VENTURE: CSK) (FRANKFURT: 9BN1) (WKN: A2DG59) (OTC PINK: BNCIF) (the "Company" or "CobalTech"), reports that as a result of a review by the British Columbia Securities Commission ("BCSC") we are issuing the following news...Read More

Castle Silver Resources Underground Sample Returns High-Grade Cobalt and Gold, Drilling Continues, Private Placement Closes - Video Available on Investmentpitch.com

2017-07-24 / @newsfile

Vancouver, British Columbia--(Newsfile Corp. - July 24, 2017) -Castle Silver Resources (TSXV: CSR) (OTC: TAKRF) (FSE: 4T9B), has issued a shareholder update. An 82-kilogram sample of vein material was recently taken from the first level of its flagship past producing high-grade Castle Silver-Cobalt...Read More

Alabama Graphite Receives ADEM Permit for Final Infill Trenching Program for the Coosa Graphite Project Feasibility Study

2017-07-24 / @marketwired

The Energy Graphite(TM) Company Sourced and Manufactured in the United States of America TORONTO, ONTARIO--(Marketwired - July 24, 2017) - Alabama Graphite Corp. ("AGC" or the "Company") (TSX VENTURE:CSPG)(OTCQB:CSPGF)(FRANKFURT:1AG) is pleased to announce receipt of the necess...Read More

CSL Behring Receives Orphan-Drug Exclusivity for HAEGARDA (R) (C1 Esterase Inhibitor Subcutaneous [Human])

2017-07-21 / @newswire

KING OF PRUSSIA, Pa., July 21, 2017 /PRNewswire/ -- Global biotherapeutics leader CSL Behring announced today that the U.S. Food and Drug Administration (FDA) has granted the Company seven years of orphan-drug exclusivity for HAEGARDA (R) (C1 Esterase Inhibitor Subcutaneous [Human]), the first and...Read More

Share to Youtube Share to Facebook Facebook Share to Linkedin Share to Twitter Twitter Share to Tiktok